Author:
Palomba Stefano,Orio Francesco,Russo Tiziana,Falbo Angela,Tolino Achille,Manguso Francesco,Nunziata Vincenzo,Mastrantonio Pasquale,Lombardi Gaetano,Zullo Fulvio
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference43 articles.
1. Sharpe M, Noble S, Spencer MC (2001) Alendronate. An update of its use in osteoporosis. Drugs 61:999–1039
2. Delmas PD (2002) Treatment of postmenopausal osteoporosis. Lancet 359:2018–2026
3. Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HAP, Recker RR, Harris ST, Wu W, Genant HK, Black MD, Eastell R (2002) Efficacy of Raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from randomized clinical trial. J Clin Endocrinol Metab 87:3609–3617
4. Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestins in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial. JAMA 17:321–333
5. Marcus R, Wong M, Heath H 3rd, Stock JL (2002) Antiresorptive treatment of postmenopausal osteoporosis: Comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocr Rev 23:16–37
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献